Mark E. Mailliard

1.5k total citations
39 papers, 1.1k citations indexed

About

Mark E. Mailliard is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Mark E. Mailliard has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 15 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Mark E. Mailliard's work include Liver Disease Diagnosis and Treatment (13 papers), Amino Acid Enzymes and Metabolism (8 papers) and Hepatitis C virus research (8 papers). Mark E. Mailliard is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Amino Acid Enzymes and Metabolism (8 papers) and Hepatitis C virus research (8 papers). Mark E. Mailliard collaborates with scholars based in United States, Germany and Netherlands. Mark E. Mailliard's co-authors include Dean J. Tuma, Michael F. Sorrell, Kusum K. Kharbanda, Harriet C. Beckenhauer, Anthony J. Barak, Bruce R. Stevens, Giovanni E. Mann, Josh Levitsky, John L. Gollan and Gary D. Volentine and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Hepatology.

In The Last Decade

Mark E. Mailliard

39 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Mailliard United States 18 447 305 289 217 212 39 1.1k
Antonio Martín‐Duce Spain 16 410 0.9× 111 0.4× 552 1.9× 151 0.7× 364 1.7× 29 1.3k
Mieko Iwahashi United States 19 355 0.8× 122 0.4× 506 1.8× 221 1.0× 42 0.2× 27 1.4k
Patricia Aspichueta Spain 21 778 1.7× 92 0.3× 585 2.0× 160 0.7× 111 0.5× 51 1.5k
E. Schmidt Germany 22 331 0.7× 104 0.3× 278 1.0× 150 0.7× 54 0.3× 79 1.2k
Stephen A. Borowsky United States 9 490 1.1× 514 1.7× 292 1.0× 148 0.7× 29 0.1× 12 1.1k
A Chedid United States 12 460 1.0× 373 1.2× 115 0.4× 256 1.2× 38 0.2× 28 803
Oscar A. Iseri United States 14 377 0.8× 380 1.2× 295 1.0× 192 0.9× 21 0.1× 22 1.2k
Pekka Pikkarainen Finland 15 519 1.2× 324 1.1× 146 0.5× 313 1.4× 29 0.1× 24 1.2k
Benita L. McVicker United States 18 277 0.6× 264 0.9× 216 0.7× 87 0.4× 31 0.1× 50 788
David Fernández‐Ramos Spain 18 309 0.7× 43 0.1× 717 2.5× 132 0.6× 124 0.6× 31 1.1k

Countries citing papers authored by Mark E. Mailliard

Since Specialization
Citations

This map shows the geographic impact of Mark E. Mailliard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Mailliard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Mailliard more than expected).

Fields of papers citing papers by Mark E. Mailliard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Mailliard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Mailliard. The network helps show where Mark E. Mailliard may publish in the future.

Co-authorship network of co-authors of Mark E. Mailliard

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Mailliard. A scholar is included among the top collaborators of Mark E. Mailliard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Mailliard. Mark E. Mailliard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Samson, Kaeli, et al.. (2023). Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic. Digestive Diseases and Sciences. 68(12). 4381–4388. 1 indexed citations
2.
Mailliard, Mark E., et al.. (2009). Outcomes of a patient‐to‐patient outbreak of genotype 3a hepatitis C†. Hepatology. 50(2). 361–368. 8 indexed citations
3.
Erickson, Judi, et al.. (2007). Hepatitis-C prevalence in an urban native-American clinic: a prospective screening study.. PubMed. 99(4). 389–92. 21 indexed citations
4.
Kharbanda, Kusum K., Mark E. Mailliard, Anthony J. Barak, et al.. (2005). A Comparison of the Effects of Betaine and S-Adenosylmethionine on Ethanol-Induced Changes in Methionine Metabolism and Steatosis in Rat Hepatocytes. Journal of Nutrition. 135(3). 519–524. 69 indexed citations
5.
Mailliard, Mark E. & John L. Gollan. (2005). Emerging Therapeutics for Chronic Hepatitis B. Annual Review of Medicine. 57(1). 155–166. 28 indexed citations
6.
Kharbanda, Kusum K., Mark E. Mailliard, Anthony J. Barak, et al.. (2005). Role of elevated S-adenosylhomocysteine in rat hepatocyte apoptosis: Protection by betaine. Biochemical Pharmacology. 70(12). 1883–1890. 80 indexed citations
7.
Freeman, Thomas L., Geoffrey M. Thiele, Lynell W. Klassen, Bryan T. Klassen, & Mark E. Mailliard. (2004). N-(methylamino)isobutyric acid inhibits proliferation of CFSC-2C hepatic stellate cells. Biochemical Pharmacology. 68(2). 223–230. 1 indexed citations
8.
9.
Freeman, Thomas L., Kusum K. Kharbanda, Dean J. Tuma, & Mark E. Mailliard. (2002). Inhibition of hepatic stellate cell collagen synthesis by N-(methylamino)isobutyric acid. Biochemical Pharmacology. 63(4). 697–706. 4 indexed citations
10.
Eubank, Darrell W., et al.. (2002). Phosphoenolpyruvate Carboxykinase Is Induced in Growth-Arrested Hepatoma Cells. Biochemical and Biophysical Research Communications. 290(5). 1513–1520. 7 indexed citations
11.
Freeman, Thomas L., Geoffrey M. Thiele, Dean J. Tuma, Tina K. Machu, & Mark E. Mailliard. (2002). ATA2-mediated amino acid uptake following partial hepatectomy is regulated by redistribution to the plasma membrane. Archives of Biochemistry and Biophysics. 400(2). 215–222. 9 indexed citations
12.
Freeman, Thomas L. & Mark E. Mailliard. (2000). Posttranscriptional Regulation of ATA2 Transport during Liver Regeneration. Biochemical and Biophysical Research Communications. 278(3). 729–732. 8 indexed citations
13.
Freeman, Thomas L., et al.. (1999). Inhibition of system A amino acid transport and hepatocyte proliferation following partial hepatectomy in the rat. Hepatology. 30(2). 437–444. 37 indexed citations
14.
Mailliard, Mark E., Bruce R. Stevens, & Giovanni E. Mann. (1995). Amino acid transport by small intestinal, hepatic, and pancreatic epithelia. Gastroenterology. 108(3). 888–910. 98 indexed citations
15.
Mailliard, Mark E., et al.. (1994). Impairment of glucagon-induced hepatic system a activity by short-term ethanol administration in the rat. Gastroenterology. 106(2). 480–487. 3 indexed citations
16.
Mailliard, Mark E.. (1993). Amino acid transport and glutathione homeostasis: What is the mechanism for cysteine uptake from bile?. Hepatology. 18(3). 700–702. 3 indexed citations
17.
Rand, Kenneth H., Herbert Houck, Mathew E. Brunson, et al.. (1993). RELATIONSHIP OF THE POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS TO THE DEVELOPMENT OF HEPATITIS IN LIVER TRANSPLANT RECIPIENTS. Transplantation. 56(3). 572–576. 10 indexed citations
18.
Wolfe, M. Michael, Rin Chang, Mark E. Mailliard, & Pratima Karnik. (1992). The effects of peptide histidine isoleucine on antral gastrin and somatostatin. Molecular and Cellular Endocrinology. 84(1-2). 89–97. 1 indexed citations
19.
Bode, Barrie P., Balaji Tamarappoo, Mark E. Mailliard, & Michael S. Kilberg. (1990). Characteristics and Regulation of Hepatic Glutamine Transport. Journal of Parenteral and Enteral Nutrition. 14(4S). 51S–55S. 23 indexed citations
20.
Mailliard, Mark E., et al.. (1989). Effect of antibodies to the neuropeptide GRP on distention-induced gastric acid secretion in the rat. Regulatory Peptides. 26(3). 287–296. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Martín‐Duce Breakdown of academic impact, for papers by Mieko Iwahashi Breakdown of academic impact, for papers by Patricia Aspichueta Breakdown of academic impact, for papers by E. Schmidt Breakdown of academic impact, for papers by Stephen A. Borowsky Breakdown of academic impact, for papers by A Chedid Breakdown of academic impact, for papers by Oscar A. Iseri Breakdown of academic impact, for papers by Pekka Pikkarainen Breakdown of academic impact, for papers by Benita L. McVicker Breakdown of academic impact, for papers by David Fernández‐Ramos
Rankless by CCL
2026